最後更新 2024-11-21 16:29:10 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

10.1%


截至2024-06-30

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

史密斯 & 內弗有限公司及其子公司在全球範圍內開發、製造、行銷和銷售醫療器械。該公司提供膝關節置換手術用的膝關節植入產品;用於髖關節重建的髖關節植入物;以及包括用於嚴重骨折和畸形矯正手術的內部和外部設備的創傷和肢體產品。它還提供供外科醫生使用的運動醫學關節修復產品,包括執行關節微創手術所需的儀器、技術和植入物,如軟組織損傷和膝關節、髖關節和肩關節的退行性疾病的修復,以及半月板修復系統。此外,該公司還提供關節可視化輔助的關節鏡手術技術,包括用於手術通路的流體管理設備、高清攝像機、數字圖像捕捉、內窺鏡、光源和顯示器,以及用於損傷組織切除的射頻、電動和機械組織切除設備,以及手術器械;以及耳鼻喉解決方案。此外,它還提供用於治療和預防急性和慢性創傷(包括腿部、糖尿病和壓力性潰瘍、燒傷和術後創傷)的先進傷口護理產品;包括用於清創和皮膚修復/再生的生物製品和其他生物活性技術,以及包括皮膚、骨移植和關節軟骨替代品的再生醫學產品;以及傳統和一次性負壓傷口治療以及水刀手術系統等先進傷口設備。它主要為醫療保健提供者服務。史密斯 & 內弗有限公司成立於1856年,總部位於英國沃特福德。



Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

所屬產業

所屬類股
Healthcare
所屬產業
Medical - Devices

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning